CIPRODEX® Otic is a prescription ear drop with both an antibiotic and anti-inflammatory corticosteroid medicine used to treat certain types of ear infections caused by certain bacteria including Middle Ear Infection (Acute Otitis Media) in children at least 6 months of age who have tympanostomy tubes and Outer Ear Canal Infection (Acute Otitis Externa, known as “Swimmer’s Ear”) in adults and in children at least 6 months of age2.
An anti-inflammatory corticosteroid was added to CIPRODEX® Otic to aid in the resolution of the inflammatory response accompanying bacterial infection (such as ear drainage in pediatric patients with Middle Ear Infection with Tubes).
CIPRODEX® Otic is an ear drop that contains two medicines, an antibiotic medicine called ciprofloxacin and an anti-inflammatory corticosteroid medicine called dexamethasone. It is used to treat certain types of ear infections caused by certain bacteria.
Do not use CIPRODEX® Otic if you2:
The recommended dosage regimen for the treatment of Outer Ear Canal Infection and Middle Ear Infection with Tubes is four drops instilled into the affected ear twice daily for seven days. Do not stop using CIPRODEX® Otic unless your doctor tells you to, even if your symptoms improve2.
Use the CIPRODEX® Otic Dosing Card (Download Coming Soon) to keep track of your doses.
You should store CIPRODEX® Otic at room temperature between 68°F to 77°F. Do not freeze CIPRODEX® Otic. Keep CIPRODEX® Otic out of light.
Keep CIPRODEX® Otic and all medicines out of the reach of children.
The Co-Pay Savings program is an offer for eligible commercially insured patients that may help them save money on their CIPRODEX® Otic Prescription Co-Pay at the pharmacy. This offer is not valid for patients who are enrolled in Medicare Part D, Medicaid, Medigap, VA, DOD, Tricare, or any other government-run or government-sponsored healthcare program with a pharmacy benefit. Additional terms and conditions apply. Click here for Terms and Conditions.
*Terms and Conditions: Limitations apply. For commercially insured patients. Up to a $135 cap per bottle. Patient will be responsible for any co-pay once limit per bottle is reached. This offer is not valid under Medicare, Medicaid, or any other federal or state program. Not valid for cash-paying patients. Novartis reserves the right to rescind, revoke, or amend this program without notice. Offer expires [9/30/2017].